Periampullary Cancer ESPAC-3(v2) trial: a Randomised Controlled Phase III Trial of Adjuvant Chemotherapy Versus Observation in Patients With Periampullary Adenocarcinomas of the Head of the Pancreas

被引：0

作者：

Neoptolemos, J. ^{[1
]}

Moore, M.

Cox, T. ^{[1
]}

Valle, J. ^{[2
]}

Palmer, D. ^{[1
]}

Mcdonald, A. ^{[3
]}

Carter, R. ^{[4
]}

Tebbutt, N. ^{[5
]}

Dervenis, C. ^{[6
]}

Smith, D. ^{[1
]}

Glimelius, B. ^{[7
]}

Coxon, F. ^{[8
]}

Lacaine, F. ^{[9
]}

Middleton, M. ^{[10
]}

Ghaneh, P. ^{[1
]}

Bassi, C. ^{[11
]}

Halloran, C. ^{[1
]}

Olah, A. ^{[12
]}

Rawcliffe, C. ^{[1
]}

Buechler, M. ^{[13
]}

机构：

[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England

[2] Christie, Manchester, Lancs, England

[3] Univ Birmingham, Birmingham B15 2TT, W Midlands, England

[4] Glasgow Royal Infirm, Glasgow, Lanark, Scotland

[5] Austin Hosp, Heidelberg, Vic 3084, Australia

[6] Aiga Olga, Athens, Greece

[7] Univ Uppsala Hosp, Uppsala, Sweden

[8] No Canc Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[9] Hosp Tenon, Paris, France

[10] John Radcliffe Hosp, Oxford OX3 9DU, England

[11] Univ Verona, I-37100 Verona, Italy

[12] Petz Aladar Hosp, Gyor, Hungary

[13] Univ Heidelberg, D-6900 Heidelberg, Germany

来源：

PANCREAS | 2011年 / 40卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1343 / 1343

页数：1

共 50 条

[1] Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater
Neoptolemos, J. P.
Moore, M. J.
Cox, T. F.
Valle, J. W.
Palmer, D. H.
Mcdonald, A.
Carter, R.
Tebbutt, N. C.
Dervenis, C.
Smith, D.
Glimelius, B.
Coxon, F. Y.
Lacaine, F.
Middleton, M. R.
Ghaneh, P.
Bassi, C.
Halloran, C.
Olah, A.
Rawcliffe, C. L.
Buechler, M. W.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
[2] Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial
Neoptolemos, John P.
Moore, Malcolm J.
Cox, Trevor F.
Valle, Juan W.
Palmer, Daniel H.
McDonald, Alexander C.
Carter, Ross
Tebbutt, Niall C.
Dervenis, Christos
Smith, David
Glimelius, Bengt
Charnley, Richard M.
Lacaine, Francois
Scarfe, Andrew G.
Middleton, Mark R.
Anthoney, Alan
Ghaneh, Paula
Halloran, Christopher M.
Lerch, Markus M.
Olah, Attila
Rawcliffe, Charlotte L.
Verbeke, Caroline S.
Campbell, Fiona
Buechler, Markus W.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (02): : 147 - 156
[3] Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater
Neoptolemos, J. P.
Moore, M. J.
Cox, T. F.
Valle, J. W.
Palmer, D. H.
Mcdonald, A.
Carter, R.
Tebbutt, N. C.
Dervenis, C.
Smith, D.
Glimelius, B.
Coxon, F. Y.
Lacaine, F.
Middleton, M. R.
Ghaneh, P.
Bassi, C.
Halloran, C.
Olah, A.
Rawcliffe, C. L.
Buechler, M. W.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[4] Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial (vol 308, pg 147, 2012)
Neoptolemos, John P.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (18): : 1861 - 1861
[5] ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma
Neoptolemos, J.
Buechler, M.
Stocken, D. D.
Ghaneh, P.
Smith, D.
Bassi, C.
Moore, M.
Cunningham, D.
Dervenis, C.
Goldstein, D.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[6] ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma
Neoptolemos, J.
Buechler, M.
Stocken, D. D.
Ghaneh, P.
Smith, D.
Bassi, C.
Moore, M.
Cunningham, D.
Dervenis, C.
Goldstein, D.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
[7] Adjuvant Intra-Arterial Chemotherapy and Radiotherapy Versus Surgery Alone in Resectable Pancreatic and Periampullary Cancer A Prospective Randomized Controlled Trial
Morak, Marjolein J. M.
van der Gaast, Ate
Incrocci, Luca
van Dekken, Herman
Hermans, John J.
Jeekel, Johannes
Hop, Wim C. J.
Kazemier, Geert
van Eijck, Casper H. J.
ANNALS OF SURGERY, 2008, 248 (06) : 1031 - 1041
[8] Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer:: a multicentre randomised controlled phase III trial
Nordlinger, B
Rougier, P
Arnaud, JP
Debois, M
Wils, J
Ollier, JC
Grobost, O
Lasser, P
Wals, J
Lacourt, J
Seitz, JF
dos Santos, JG
Bleiberg, H
Mackiewickz, R
Conroy, T
Bouché, O
Morin, T
Baila, L
van Cutsem, E
Bedenne, L
LANCET ONCOLOGY, 2005, 6 (07): : 459 - 468
[9] Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
van Hilst, Jony
de Rooij, Thys
Bosscha, Koop
Brinkman, David J.
van Dieren, Susan
Dijkgraaf, Marcel G.
Gerhards, Michael F.
de Hingh, Lgnace H.
Karsten, Tom M.
Lips, Daniel J.
Luyer, Misha D.
Busch, Olivier R.
Festen, Sebastiaan
Besselink, Marc G.
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (03): : 199 - 207
[10] Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region - Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group
Klinkenbijl, JH
Jeekel, J
Sahmoud, T
van Pel, R
Couvreur, ML
Veenhof, CH
Arnaud, JP
Gonzalez, DG
de Wit, LT
Hennipman, A
Wils, J
ANNALS OF SURGERY, 1999, 230 (06) : 776 - 782

← 1 2 3 4 5 →